Framework
The Data Liability Paradox
In regulated industries, more data creates more liability before it creates better outcomes. Clinical validation of when to act is as valuable as the data itself.
How it works
- 1A physician with access to a data point is potentially expected to act on it — in litigious specialties, that exposure matters before protocols exist to guide the response.
- 2Until clinical studies specify which signals are actionable and which are noise, collecting more data can increase physician risk without improving patient outcomes.
- 3Publishing clinical validation studies — showing when a given biometric requires intervention — is product work, not academic work; it is what unlocks adoption.
- 4For health tech founders: the technical challenge of collecting data is easier than the clinical challenge of knowing what the data means; sequence accordingly.
- 5The path through the paradox is evidence: prospective studies, published outcomes, and protocol libraries that give physicians a defensible basis for acting on the data you provide.
Hear it on the podcast
AI Is Rewiring Pregnancy Care: Babyscripts CEO on RPM, Risk, and Real OutcomesListen to the episodeMore from this episode
The Remote Monitoring Closed LoopThe value of remote patient monitoring is not data collection — it is completing the loop between patient, device, and care team in real time.AI Documentation Before AI DiagnosisThe first wave of AI adoption in clinical settings is administrative, not diagnostic. Automate the burden layer before the judgment layer.
Get the next framework first
One email a week with the frameworks, tools, and founder stories from the podcast. Free.
More frameworks for Operations & Scaling
The Trust Decay CurveWhy fraud almost never comes from strangers.The Built to Sell Operating SystemHow Anthony abstracts himself out of the business.The Found Money AuditMatt's core operating loop: assume the leak already exists and go looking for it.Transparent Cost-Plus EOR ModelAlways show clients exactly what goes to the employee versus what goes to the service provider. Opaque pricing creates incentives to compress employee compensation - transparent pricing aligns everyone around fair wages and prevents exploitative reverse tendering.Three-Track IP StrategyOphir's framework for choosing between the three available IP protection vehicles based on the nature of the invention, competitive environment, and operational realities. Patent, trade secret, and defensive publication each solve a different problem — and the wrong choice can leave you either over-exposed or locked into disclosure requirements that hurt more than they help.Provisional-as-Priority StakeThe provisional patent application is the most underused tool in the founder's legal stack. Under the America Invents Act, the US runs first-to-file: whoever reaches the patent office first wins priority, regardless of who invented first. A provisional costs $65 for a micro-entity, requires no formal claims, and grants 12 months of patent-pending status. The gap between 700K non-provisional applications and only 170K provisionals per year is a market failure — not a founder behavior problem. The gatekeeper was always attorney economics, not founder willingness.